Sachet A. Shukla

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Abstract 1495: A novel, deep learning -based filtering tool for enhanced detection of technical artifacts in whole-genome sequencing data

  Cancer Research · 2026-04-03

• Abstract 3075: FGFR2b is a highly prevalent and actionable cell surface target in intrahepatic cholangiocarcinoma

  Cancer Research · 2026-04-03

• Abstract PR001: Exploiting HIF-driven endogenous retroviral neoantigens to advance kidney cancer immunotherapy

  Cancer Research · 2026-03-13

• Data from PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor–Resistant Chronic Lymphocytic Leukemia

  2026-01-12

• PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor–Resistant Chronic Lymphocytic Leukemia

  Blood Cancer Discovery · 2025-11-05 · 1 citations

• 119 Endogenous retroviruses as tumor-specific antigens in clear cell renal cell carcinoma: A new avenue for immunotherapy

  Regular and Young Investigator Award Abstracts · 2025-11-01

• 1228 Immune escape through oncogene-mediated editing of the HLA-ligandome

  Regular and Young Investigator Award Abstracts · 2025-11-01

• 2601P Peripheral and tumor cytokines in exceptional responders to immunotherapy: Results from a phase III trial

  Annals of Oncology · 2025-09-01

• A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma

  Cell · 2025-07-15 · 30 citations

• Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell Carcinoma

  Journal of Clinical Oncology · 2025-07-02 · 11 citations

• Smoking habit and long-term colorectal cancer incidence by exome-wide mutational and neoantigen loads: evidence based on the prospective cohort incident-tumour biobank method

  BMJ Oncology · 2025-06-01 · 9 citations

• <i>ASXL1</i> truncating mutations drive leukemic resistance to T cell attackPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-06-01

• 831 AXL Receptor Tyrosine Kinase Expression in Metastatic Renal Cell Carcinoma: Insights from the METEOR trial

  Laboratory Investigation · 2025-03-01 · 2 citations

• HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy

  Cell · 2025-02-28 · 54 citations

• Metabolic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.

  Journal of Clinical Oncology · 2025-02-10 · 1 citations

• Investigation of ferroptosis and mTOR signaling in chromophobe renal cell carcinoma (ChRCC).

  Journal of Clinical Oncology · 2025-02-10

• A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

  Nature · 2025-02-05 · 166 citations

• Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma

  Nature Cancer · 2025-01-09 · 26 citations

• Multiomic Single Cell Profiling Identifies Drivers of Progression in T-Cell Prolymphocytic Leukemia

  Blood · 2024-11-05

• EXTH-83. CHARACTERIZATION OF SPLICING ABERRATIONS INDUCED BY PRMT5 INHIBITION IN GLIOBLASTOMA

  Neuro-Oncology · 2024-11-01